Perception, SelfPOWER-BENCT06599268
Analyzing the Barriers and Enablers for Women Reaching Top Executive Positions in the Pharmaceutical Sector
An observational study of Perception, Self, run by Lebanese University at 1 site in Lebanon.
Trial summary
Research into the barriers and enablers for women's advancement in the pharmaceutical sector highlights several key factors. On the one hand, systemic issues such as gender bias, the glass ceiling, and the lack of adequate mentorship prevent many women from reaching executive roles. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Perception, Self
- What is being tested?
- Survey using a questionnaire.
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 275 participants
- Where
- 1 siteLebanon
- Study dates
- 15 Jul 2024to 30 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Pharmacists/Pharmacy Students working in pharmaceutical companies
Who may be able to join
- Pharmacists/Pharmacy Students
- Working in companies/Community pharmacies
Who cannot join
- Non-Lebanese
- Those unemployed or Free-lancer
- Those working for companies outside Lebanon
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Women in Pharmaceutical Executive Roles: Analyzing the Barriers and Enablers for Women Reaching Top Executive Positions in Pharmaceutical Companies and Pharmacies
Research into the barriers and enablers for women's advancement in the pharmaceutical sector highlights several key factors. On the one hand, systemic issues such as gender bias, the glass ceiling, and the lack of adequate mentorship prevent many women from reaching executive roles. These barriers are often compounded by societal expectations, family responsibilities, and the rigid structures of work environments that disproportionately affect women. On the other hand, enabling factors like strong mentorship, diversity policies, leadership development programs, and workplace flexibility have proven to help women overcome these challenges and climb the corporate ladder. Companies that actively promote inclusive cultures and provide opportunities for women to develop leadership skills have seen greater success in gender diversity at the executive level.
Understanding the dynamics of women's leadership in pharmaceuticals is particularly relevant in regions like Lebanon, where cultural and social norms heavily influence gender roles. Although women in Lebanon are increasingly pursuing careers in healthcare and pharmaceuticals, few reach executive positions due to a combination of cultural expectations and structural limitations within companies. Analyzing the barriers and enablers for women's leadership in this context is crucial, as Lebanon's healthcare and pharmaceutical sectors play a vital role in the country's economy and well-being. Including women in leadership roles could enhance decision-making, foster innovation, and lead to more balanced workplace environments. Moreover, in a country with a history of political instability and economic challenges, addressing gender disparity in leadership becomes not just a matter of equality but one of economic necessity. Women bring diverse perspectives and leadership styles that can help companies navigate complex markets, drive performance, and foster sustainability. In the Lebanese pharmaceutical sector, where the demand for skilled professionals and innovative leadership is high, unlocking the potential of women in executive roles can lead to more resilient and adaptable organizations.
Read the detailed description
The study titled Women in Pharmaceutical Executive Roles: Analyzing the barriers and enablers for women reaching top executive positions in pharmaceutical companies and pharmacies; focuses on exploring the factors that either hinder or support women in attaining leadership positions in the pharmaceutical industry.
Overview:
Context: The pharmaceutical industry has a notable gender disparity in executive roles, despite significant female participation in the workforce. Women often face systemic barriers like gender bias, lack of mentorship, and societal expectations that limit their upward mobility.
Region of Focus: Lebanon, where cultural norms play a substantial role in shaping gender roles. Despite women being increasingly involved in healthcare, few reach executive positions due to these societal and structural barriers.
Objective: The study aims to identify these barriers and enablers to improve gender diversity in leadership, especially in Lebanon s pharmaceutical sector, which is crucial for its economy.
Methodology:
Population: The study targets pharmacists and pharmacy students working in pharmaceutical companies and pharmacies.
Exposure: It examines personal perceptions of workplace environments, especially in the context of Lebanon s post-pandemic and economic crisis.
Comparison and Data Collection: A questionnaire was designed to assess barriers and enablers using Likert scales across various sections:
General characteristics of participants Work-related characteristics Barriers faced by women in reaching executive roles Enablers for women's advancement Perceptions of women in the pharmaceutical sector Setting: The questionnaire is distributed online via platforms like Facebook, WhatsApp, and LinkedIn, aiming for 275 respondents. The data collection started in July 2024 and is ongoing.
Expected Outcomes:
Final theses for three MBA students at the Lebanese University, Faculty of Pharmacy.
A scientific publication in a peer-reviewed journal. A poster presentation at an international conference.
The study aims to highlight the importance of inclusive company cultures and leadership development programs that can pave the way for women to climb to executive positions in the pharmaceutical sector, ultimately fostering more innovative and adaptable organizations in Lebanon .
- Conditions
- Perception, Self
- Being tested
- Survey using a questionnaire.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Survey using a questionnaire.Behavioural
Questionnaire to assess the barriers and enablers for women reaching top executive positions in pharmaceutical companies and pharmacies
The following sections will be considered:
- General Characteristics of the Participants
- Work-related characteristics
- Barriers faced by women to reach top executive positions (Likert scale)
- Enablers for women to reach top executive positions (Likert scale)
- Conception of women in the pharmaceutical sector (Likert scale)
| Study group | Role | What they receive |
|---|---|---|
| Pharmacists | Pharmacists/Pharmacy Students working in pharmaceutical companies or communities among others Receives: Behavioral: Survey using a questionnaire. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation between the score of the schemes, as mentioned earlier, and the participants general characteristics.
The likert scale per scheme will be transformed into a score and associated with the participants characteristics
Measured: through study completion, an average of 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start15 Jul 2024
- Primary completion15 Nov 2024
- Study completion30 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Perception, SelfStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 275 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lebanese University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Georges Hatem, Lebanese University
- Investigators
- Georges Hatem, Principal investigator, Lebanese University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06599268
- Sponsor's protocol ID
- 17/24/D
- Acronym
- POWER-BE
- Status last verified
- Mar 2025
- First submitted
- 11 Sep 2024
- Last updated
- 4 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Women in Pharmaceutical Executive Roles: Analyzing the Barriers and Enablers for Women Reaching Top Executive Positions in Pharmaceutical Companies and Pharmacies
- ClinicalTrials.gov ID
- NCT06599268
- Acronym / sponsor ID
- POWER-BE / 17/24/D
- Conditions
- Perception, Self
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 275 participants (actual)
- Lead sponsor
- Lebanese UniversityUniversity, hospital or other
- Study start
- 15 Jul 2024 (actual)
- Primary completion
- 15 Nov 2024 (actual)
- Study completion
- 30 Dec 2024 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Research into the barriers and enablers for women's advancement in the pharmaceutical sector highlights several key factors. On the one hand, systemic issues such as gender bias, the glass ceiling, and the lack of adequate mentorship prevent many women from reaching executive roles. These barriers are often compounded by societal expectations, family responsibilities, and the rigid structures of work environments that disproportionately affect women. On the other hand, enabling factors like strong mentorship, diversity policies, leadership development programs, and workplace flexibility have proven to help women overcome these challenges and climb the corporate ladder. Companies that actively promote inclusive cultures and provide opportunities for women to develop leadership skills have seen greater success in gender diversity at the executive level.
Understanding the dynamics of women's leadership in pharmaceuticals is particularly relevant in regions like Lebanon, where cultural and social norms heavily influence gender roles. Although women in Lebanon are increasingly pursuing careers in healthcare and pharmaceuticals, few reach executive positions due to a combination of cultural expectations and structural limitations within companies. Analyzing the barriers and enablers for women's leadership in this context is crucial, as Lebanon's healthcare and pharmaceutical sectors play a vital role in the country's economy and well-being. Including women in leadership roles could enhance decision-making, foster innovation, and lead to more balanced workplace environments. Moreover, in a country with a history of political instability and economic challenges, addressing gender disparity in leadership becomes not just a matter of equality but one of economic necessity. Women bring diverse perspectives and leadership styles that can help companies navigate complex markets, drive performance, and foster sustainability. In the Lebanese pharmaceutical sector, where the demand for skilled professionals and innovative leadership is high, unlocking the potential of women in executive roles can lead to more resilient and adaptable organizations.
Detailed description
The study titled Women in Pharmaceutical Executive Roles: Analyzing the barriers and enablers for women reaching top executive positions in pharmaceutical companies and pharmacies; focuses on exploring the factors that either hinder or support women in attaining leadership positions in the pharmaceutical industry.
Overview:
Context: The pharmaceutical industry has a notable gender disparity in executive roles, despite significant female participation in the workforce. Women often face systemic barriers like gender bias, lack of mentorship, and societal expectations that limit their upward mobility.
Region of Focus: Lebanon, where cultural norms play a substantial role in shaping gender roles. Despite women being increasingly involved in healthcare, few reach executive positions due to these societal and structural barriers.
Objective: The study aims to identify these barriers and enablers to improve gender diversity in leadership, especially in Lebanon s pharmaceutical sector, which is crucial for its economy.
Methodology:
Population: The study targets pharmacists and pharmacy students working in pharmaceutical companies and pharmacies.
Exposure: It examines personal perceptions of workplace environments, especially in the context of Lebanon s post-pandemic and economic crisis.
Comparison and Data Collection: A questionnaire was designed to assess barriers and enablers using Likert scales across various sections:
General characteristics of participants Work-related characteristics Barriers faced by women in reaching executive roles Enablers for women's advancement Perceptions of women in the pharmaceutical sector Setting: The questionnaire is distributed online via platforms like Facebook, WhatsApp, and LinkedIn, aiming for 275 respondents. The data collection started in July 2024 and is ongoing.
Expected Outcomes:
Final theses for three MBA students at the Lebanese University, Faculty of Pharmacy.
A scientific publication in a peer-reviewed journal. A poster presentation at an international conference.
The study aims to highlight the importance of inclusive company cultures and leadership development programs that can pave the way for women to climb to executive positions in the pharmaceutical sector, ultimately fostering more innovative and adaptable organizations in Lebanon .
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pharmacists | – | Behavioral: Survey using a questionnaire.Pharmacists/Pharmacy Students working in pharmaceutical companies or communities among others |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Pharmacists/Pharmacy Students working in pharmaceutical companies
Key inclusion criteria (2 listed)
- Pharmacists/Pharmacy Students
- Working in companies/Community pharmacies
Key exclusion criteria (3 listed)
- Non-Lebanese
- Those unemployed or Free-lancer
- Those working for companies outside Lebanon
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Survey using a questionnaire.Questionnaire to assess the barriers and enablers for women reaching top executive positions in pharmaceutical companies and pharmacies The following sections will be considered: * General Characteristics of the Participants * Work-related characteristics * Barriers faced by women to reach top executive positions (Likert scale) * Enablers for women to reach top executive positions (Likert scale) * Conception of women in the pharmaceutical sector (Likert scale) | Behavioural | Pharmacists |
Primary outcome
Correlation between the score of the schemes, as mentioned earlier, and the participants general characteristics.
Time frame: through study completion, an average of 3 months
The likert scale per scheme will be transformed into a score and associated with the participants characteristics
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Mar 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Perception, Self
Not yet recruiting
Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair
Androgenetic Alopecia
RecruitingObservational study
Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors
Quality of Life, Breast Neoplasms
Not yet recruiting
Genital Self İmage and Satisfaction With Genital Appearance
Women
Recruiting
Prenatal Yoga Intervention in Pregnant Women
Pregnant Women, Prenatal Yoga
Not yet recruitingObservational study
Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease
PARKINSON DISEASE (Disorder), Older Adults (65-85 Years)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Georges Hatem principal investigator
Lebanese University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Perception, Self, run by Lebanese University at 1 site in Lebanon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation between the score of the schemes, as mentioned earlier, and the participants general characteristics. (time frame: through study completion, an average of 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2025.